Publikationen des AMSP-Projektes

Hier finden Sie eine Auflistung der zahlreichen Publikationen des AMSP-Projektes. Ziel unserer Publikationen von Einzelfällen, Fallreihen und statistischen Auswertungen ist es, das im AMSP-Projekt gesammelte Wissen zu unerwünschten Wirkungen von Psychopharmaka und Risikozusammenhängen der Fachwelt zugänglich zu machen und so im internationalen wissenschaftlichen Diskurs die Behandlungsqualität psychisch erkrankter Menschen zu verbessern.

2026

Originalarbeit
Greil W, de Bardeci M, Nievergelt N, Erfurth A, Hasler G, Cattapan K, Bleich S, Toto S, Seifert J, Grohmann R, Schoretsanitis G (2026). Adverse drug reactions associated with psychotropic medications combined with versus without lithium: A case/control pharmacovigilance analysis. J Psychopharmacol. Online ahead of print.
DOI: 10.1177/02698811261488471

Originalarbeit
Bleich L, Bleich S, Bleich K, Bleich J, Ortak P, Seifert J, Grohmann R, Dabbert D, Stübner S, Erfurth A, Greil W, Hasler G, Schüle C, Degner D, Toto S (2026). Severe antipsychotic-associated gastrointestinal hypomotility: AMSP pharmacovigilance data from 333,175 psychiatric inpatients. Eur Arch Psychiatry Clin Neurosci. Online ahead of print.
DOI: 10.1007/s00406-026-02381-0

Originalarbeit
Seifert J, Stübner S, Dabbert D, Greil W, Maier HB, Grohmann R, Toto S (2026). Trajectories of psychotropic drug use patterns in psychiatric inpatients with acute depressive episodes of bipolar disorder: results from a pharmacovigilance program in German-speaking countries from 2007 to 2024. Int J Bipolar Disord. 14(1):28.
DOI: 10.1186/s40345-026-00435-9

Originalarbeit
Schulze Westhoff M, Toto S, Bleich S, Grohmann R, Seifert J (2026). Pharmacological treatment of late-life major depressive disorder - Results from the AMSP drug surveillance program from 2007 to 2023. J Affect Disord. 2026;414:122322. Online veröffentlicht am 27.07.2026; Heftdatum 01.12.
DOI: 10.1016/j.jad.2026.122322

Originalarbeit
Fugger G, Rabl U, Bartova L, Popper V, Watzal V, Ivkic D, Donath J, Busvine C, Greil W, Toto S, Grohmann R, Frey R, Konstantinidis A, Erfurth A, Kasper S (2026). Secondary Restless Legs Syndrome during psychopharmacological treatment: real-world evidence from a multinational pharmacovigilance program. Int J Neuropsychopharmacol. 29(7):pyag029.
DOI: 10.1093/ijnp/pyag029

Originalarbeit
Hinney B, Jost S, Toto S, Seifert J, Erfurth A, Greil W, Horvath A, Grohmann R, Hasler G (2026). Cross-national differences in methylphenidate utilization in primarily adult psychiatric inpatients. World J Biol Psychiatry. 27(2):145-156.
DOI: 10.1080/15622975.2025.2607095

2025

Originalarbeit
Seifert J, Grohmann R, Toto S, Reinhard MA, Bleich S, Erfurth A, Schüle C, Stübner S, Glocker C (2025). A 24-year pharmacovigilance study on sex differences in adverse drug reactions to antidepressant drugs. Naunyn Schmiedebergs Arch Pharmacol.
DOI: 10.1007/s00210-025-04900-7

Originalarbeit
Haack B, Engel J, Pauwels P, Toto S, Bleich S, Seifert J, Grohmann R, Heinze M, Zolk O, Proskynitopoulos P, Greiner T, Schneider M (2025). Pharmacotherapy for psychiatric inpatients with alcohol use disorder or acute intoxication: results from an observational pharmacovigilance program-status and changes between 2000 and 2016. J Neural Transm (Vienna).
DOI: 10.1007/s00702-025-03012-z

Originalarbeit
Pauwels P, Haack B, Toto S, Seifert J, Grohmann R, Heinze M, Zolk O, Proskynitopoulos PJ, Schneider M, Greiner T (2025). Pharmacotherapy of psychiatric inpatients with mental and behavioral disorders caused by sedatives or hypnotics (F13): Results from an observational pharmacovigilance program between 2000 and 2017. Addict Sci Clin Pract. 20(1):51.
DOI: 10.1186/s13722-025-00579-6

Originalarbeit
Greil W, de Bardeci M, Nievergelt N, Erfurth A, Hasler G, Bridler R, Toto S, Grohmann R, Seifert J, Schoretsanitis G (2025). Twenty-four years of prescription patterns in bipolar disorder inpatients with vs without lithium: a pharmacoepidemiological analysis of 8,707 cases in German-speaking countries. Int J Bipolar Disord. 13(1):3.
DOI: 10.1186/s40345-025-00370-1

2024

Originalarbeit
Seifert J, Reinhard MA, Bleich S, Erfurth A, Greil W, Toto S, Grohmann R, Glocker C (2024). Psychotropic drug-induced adverse drug reactions in 462,661 psychiatric inpatients in relation to age: results from a German drug surveillance program from 1993-2016. Ann Gen Psychiatry. 23(1):47.
DOI: 10.1186/s12991-024-00530-0

Originalarbeit
Greil W, de Bardeci M, Nievergelt N, Toto S, Grohmann R, Seifert J, Schoretsanitis G (2024). Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries. Pharmacopsychiatry. 57(6):296-303.
DOI: 10.1055/a-2374-2386

Originalarbeit
Bleich L, Grohmann R, Greil W, Dabbert D, Erfurth A, Toto S, Seifert J (2024). Clozapine-associated adverse drug reactions in 38,349 psychiatric inpatients: drug surveillance data from the AMSP project between 1993 and 2016. J Neural Transm (Vienna). 131(9):1117-1134.
DOI: 10.1007/s00702-024-02818-7

Originalarbeit
Engel J, Haack B, Zolk O, Greiner T, Heinze M, Toto S, Seifert J, Bleich S, Glocker C, Grohmann R, Schneider M, Stübner S (2024). Edema related to treatment with psychotropic drugs. J Neural Transm (Vienna). 131(3):253-266.
DOI: 10.1007/s00702-024-02738-6

2023

Originalarbeit
Greil W, de Bardeci M, Müller-Oerlinghausen B, Nievergelt N, Stassen H, Hasler G, Erfurth A, Cattapan K, Rüther E, Seifert J, Toto S, Bleich S, Schoretsanitis G (2023). Controversies regarding lithium-associated weight gain: case-control study of real-world drug safety data. Int J Bipolar Disord. 11(1):34.
DOI: 10.1186/s40345-023-00313-8

Originalarbeit
Glocker C, Grohmann R, Burkhardt G, Seifert J, Bleich S, Held T, Toto S, Stübner S, Schüle C (2023). Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016. J Neural Transm (Vienna). 130(2):153-163.
DOI: 10.1007/s00702-023-02589-7

Originalarbeit
de Bardeci M, Greil W, Stassen H, Willms J, Köberle U, Bridler R, Hasler G, Kasper S, Rüther E, Bleich S, Toto S, Grohmann R, Seifert J (2023). Dear Doctor Letters regarding citalopram and escitalopram: guidelines vs real-world data. Eur Arch Psychiatry Clin Neurosci. 273(1):65-74.
DOI: 10.1007/s00406-022-01392-x

Übersichtsarbeit / Fachbeitrag
Seifert J, Eckermann G, Heck J, Bleich S, Dabbert D, Grohmann R, Toto S (2023). Das Blutungsrisiko unter Antidepressiva verstehen und einschätzen. Fortschr Neurol Psychiatr.
DOI: 10.1055/a-2089-3490

2022

Originalarbeit
Köberle U, Grohmann R, Belz M, Greil W, Degner D (2022). Effekt der Rote-Hand-Briefe zu Citalopram und Escitalopram auf Verordnungszahlen bei der stationären Behandlung von Angsterkrankungen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 65(11):1204–1212.
DOI: 10.1007/s00103-022-03594-z

Originalarbeit
Zolk O, Greiner T, Schneider M, Heinze M, Dahling V, Ramin T, Grohmann R, Bleich S, Zindler T, Toto S, Seifert J (2022). Antipsychotic drug treatment of schizophrenia in later life: Results from the European cross-sectional AMSP study. World J Biol Psychiatry. 23(5):374-386.
DOI: 10.1080/15622975.2021.2011403

Originalarbeit
Baumgärtner J, Grohmann R, Bleich S, Glocker C, Seifert J, Toto S, Rüther E, Engel RR, Stübner S (2022). Atypical dyskinesias under treatment with antipsychotic drugs: Report from the AMSP multicenter drug safety project. World J Biol Psychiatry. 23(2):151-164.
DOI: 10.1080/15622975.2021.1938213

Originalarbeit
Greil W, de Bardeci M, Seifert J, Bernegger X, Cattapan K, Stassen H, Wagner AL, Sieberer M, Grohmann R, Toto S (2022). Treatment of depression: Are psychotropic drugs appropriately dosed in women and in the elderly? Dosages of psychotropic drugs by sex and age in routine clinical practice. Hum Psychopharmacol. 37(1):e2809.
DOI: 10.1002/hup.2809

Originalarbeit
Seifert J, Maier HB, Führmann F, Bleich S, Stübner S, Sieberer M, Bernegger X, Greil W, Schüle C, Toto S, Grohmann R, Reinhard MA (2022). Pharmacological treatment of major depressive disorder according to severity in psychiatric inpatients: results from the AMSP pharmacovigilance program from 2001-2017. J Neural Transm (Vienna). 129(7):925-944.
DOI: 10.1007/s00702-022-02504-6

Originalarbeit
Friedrich ME, Grohmann R, Rabl U, Winkler D, Konstantinidis A, Engel R, Seifert J, Toto S, Stübner S, Frey R, Kasper S (2022). Incidence of Drug-Induced Delirium During Treatment With Antidepressants or Antipsychotics: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2016. Int J Neuropsychopharmacol. 25(7):556-566.
DOI: 10.1093/ijnp/pyac005

2021

Originalarbeit
Seifert J, Führmann F, Reinhard MA, Engel RR, Bernegger X, Bleich S, Stübner S, Rüther E, Toto S, Grohmann R, Sieberer M, Greil W (2021). Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017. J Neural Transm (Vienna). 128(6):827–843.
DOI: 10.1007/s00702-021-02349-5

Originalarbeit
Seifert J, Letmaier M, Greiner T, Schneider M, Deest M, Eberlein CK, Bleich S, Grohmann R, Toto S (2021). Psychotropic drug-induced hyponatremia: results from a drug surveillance program-an update. J Neural Transm (Vienna). 128(8):1249-1264.
DOI: 10.1007/s00702-021-02369-1

Übersichtsarbeit / Fachbeitrag
Moschny N, Hefner G, Grohmann R, Eckermann G, Maier HB, Seifert J, Heck J, Francis F, Bleich S, Toto S, Meissner C (2021). Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs-Influence of Smoking Behavior and Inflammation on Pharmacokinetics. Pharmaceuticals (Basel). 14(6):514.
DOI: 10.3390/ph14060514

Übersichtsarbeit / Fachbeitrag
Seifert J, Heck J, Eckermann G, Singer M, Bleich S, Grohmann R, Toto S (2021). COVID-19-Impfung unter Psychopharmakotherapie. Psychiatr Prax. 48(8):399-403.
DOI: 10.1055/a-1531-4460

Originalarbeit
Glocker C, Grohmann R, Engel R, Seifert J, Bleich S, Stübner S, Toto S, Schüle C (2021). Galactorrhea during antipsychotic treatment: results from AMSP, a drug surveillance program, between 1993 and 2015. Eur Arch Psychiatry Clin Neurosci. 271(8):1425-1435.
DOI: 10.1007/s00406-021-01241-3

Originalarbeit
Druschky K, Toto S, Bleich S, Baumgärtner J, Engel RR, Grohmann R, Maier HB, Neyazi A, Rudolph YJ, Rüther E, Schwörer H, Seifert J, Stübner S, Degner D (2021). Severe drug-induced liver injury in patients under treatment with antipsychotic drugs: Data from the AMSP study. World J Biol Psychiatry. 22(5):373-386.
DOI: 10.1080/15622975.2020.1819565

Kasuistik / Fallserie
Heck J, Seifert J, Stichtenoth DO, Schroeder C, Groh A, Szycik GR, Degner D, Adamovic I, Schneider M, Glocker C, Rüther E, Bleich S, Grohmann R, Toto S (2021). A case series of serious and unexpected adverse drug reactions under treatment with cariprazine. Clin Case Rep. 9(5):e04084.
DOI: 10.1002/ccr3.4084

Originalarbeit
Reinhard MA, Seifert J, Greiner T, Toto S, Bleich S, Grohmann R (2021). Pharmacotherapy of 1,044 inpatients with posttraumatic stress disorder: current status and trends in German-speaking countries. Eur Arch Psychiatry Clin Neurosci. 271(6):1065-1076.
DOI: 10.1007/s00406-020-01223-x

Originalarbeit
Seifert J, Engel RR, Bernegger X, Führmann F, Bleich S, Stübner S, Sieberer M, Greil W, Toto S, Grohmann R (2021). Time trends in pharmacological treatment of major depressive disorder: Results from the AMSP Pharmacovigilance Program from 2001-2017. J Affect Disord. 281:547-556.
DOI: 10.1016/j.jad.2020.12.073

Originalarbeit
Winkler D, Grohmann R, Friedrich ME, Toto S, Bleich S, Seifert J, Konstantinidis A, Shariat SF, Kasper S, Pjrek E (2021). Urological adverse drug reactions of psychotropic medication in psychiatric inpatients - A drug surveillance report from German-speaking countries. J Psychiatr Res. 144:412-420.
DOI: 10.1016/j.jpsychires.2021.10.026

2020

Übersichtsarbeit / Fachbeitrag
Seifert J, Heck J, Eckermann G, Singer M, Bleich S, Grohmann R, Toto S (2020). Psychopharmakotherapie in Zeiten der COVID-19-Pandemie. Nervenarzt. 91(7):604-610.
DOI: 10.1007/s00115-020-00939-4

Originalarbeit
Schneider M, Pauwels P, Toto S, Bleich S, Grohmann R, Heinze M, Greiner T (2020). Severe weight gain as an adverse drug reaction of psychotropics: Data from the AMSP project between 2001 and 2016. European Neuropsychopharmacology 36, 60–71.
DOI: 10.1016/j.euroneuro.2020.05.001

Originalarbeit
Mörkl S, Seltenreich D, Letmaier M, Bengesser S, Wurm W, Grohmann R, Bleich S, Toto S, Stübner S, Butler MI, Kasper S (2020). Extrapyramidal reactions following treatment with antidepressants: Results of the AMSP multinational drug surveillance programme. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 21(4), 308–316.
DOI: 10.1080/15622975.2019.1648871

Originalarbeit
Friedrich ME, Winkler D, Konstantinidis A, Huf W, Engel R, Toto S, Grohmann R, Kasper S (2020). Cardiovascular Adverse Reactions During Antipsychotic Treatment: Results of AMSP, A Drug Surveillance Program Between 1993 and 2013. The International Journal of Neuropsychopharmacology, 23(2), 67–75.
DOI: 10.1093/ijnp/pyz046

Originalarbeit
Druschky K, Bleich S, Grohmann R, Engel RR, Toto S, Neyazi A, Däubl B, Stübner S (2020). Severe parkinsonism under treatment with antipsychotic drugs. European Archives of Psychiatry and Clinical neuroscience, 270(1), 35–47.
DOI: 10.1007/s00406-019-01060-7

Originalarbeit
Greiner T, Haack B, Toto S, Bleich S, Grohmann R, Faltraco F, Heinze M, Schneider M (2020). Pharmacotherapy of psychiatric inpatients with adjustment disorder: current status and changes between 2000 and 2016. European archives of psychiatry and clinical neuroscience, 270(1), 107–117.
DOI: 10.1007/s00406-019-01058-1

Originalarbeit
Schneider M, Regente J, Greiner T, Lensky S, Bleich S, Toto S, Grohmann R, Stübner S, Heinze M (2020). Neuroleptic malignant syndrome: evaluation of drug safety data from the AMSP program during 1993-2015. Eur Arch Psychiatry Clin Neurosci. 270(1):23-33.
DOI: 10.1007/s00406-018-0959-2

2019

Originalarbeit
Druschky K, Bleich S, Grohmann R, Engel RR, Neyazi A, Stübner S, Toto S (2019). Seizure rates under treatment with antipsychotic drugs: Data from the AMSP project. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 20(9), 732–741.
DOI: 10.1080/15622975.2018.1500030

Originalarbeit
Toto S, Grohmann R, Bleich S, Frieling H, Maier HB, Greil W, Cordes J, Schmidt-Kraepelin C, Kasper S, Stübner S, Degner D, Druschky K, Zindler T, Neyazi A (2019). Psychopharmacological Treatment of Schizophrenia Over Time in 30 908 Inpatients: Data From the AMSP Study. The International Journal of Neuropsychopharmacology, 22(9), 560–573.
DOI: 10.1093/ijnp/pyz037

Kasuistik / Fallserie
Sanader B, Grohmann R, Grötsch P, Schumann T, Toto S, Fernando P, Stübner S (2019). Clozapine-Induced DRESS Syndrome: A Case Series From the AMSP Multicenter Drug Safety Surveillance Project. Pharmacopsychiatry, 52(3), 156–159.
DOI: 10.1055/a-0586-8983

Kasuistik / Fallserie
Greiner T, Schneider M, Regente J, Toto S, Bleich S, Grohmann R, Heinze M (2019). Priapism induced by various psychotropics: A case series. The World Journal of Biological Psychiatry : The Official Journal of the World Federation of Societies of Biological Psychiatry, 20(6), 505–512.
DOI: 10.1080/15622975.2018.1520396

Originalarbeit
Greil W, Zhang X, Stassen H, Grohmann R, Bridler R, Hasler G, et al (2019). Cutaneous adverse drug reactions to psychotropic drugs and their risk factors - a case-control study. European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, 29(1), 111–121.
DOI: 10.1016/j.euroneuro.2018.10.010

Kasuistik / Fallserie
Reinhard MA, Wilkening A, Müller-Oerlinghausen B, Grohmann R (2019). Recurring Nephrotic Syndrome After Lithium Medication: A Case Report. Journal of Clinical Psychopharmacology, 39(5), 516–518.
DOI: 10.1097/JCP.0000000000001078

2018

Originalarbeit
Letmaier M, Grohmann R, Kren C, Toto S, Bleich S, Engel R, et al (2018). Venous thromboembolism during treatment with antipsychotics: Results of a drug surveillance programme. The World Journal of Biological Psychiatry : The Official Journal of the World Federation of Societies of Biological Psychiatry, 19(3), 175–186.
DOI: 10.1080/15622975.2017.1285048

Originalarbeit
Druschky K, Bleich S, Grohmann R, Engel RR, Kleimann A, Stübner S, et al (2018). Use and safety of antiepileptic drugs in psychiatric inpatients-data from the AMSP study. European Archives of Psychiatry and Clinical Neuroscience, 268(2), 191–208.
DOI: 10.1007/s00406-017-0827-5

Originalarbeit
Stübner S, Grohmann R, Greil W, Zhang X, Müller-Oerlinghausen B, Bleich S, et al (2018). Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project. The International Journal of Neuropsychopharmacology, 21(9), 814–821.
DOI: 10.1093/ijnp/pyy048

Originalarbeit
Druschky K, Bleich S, Grohmann R, Burda K, Frieling H, Hillemacher T, et al (2018). Severe hair loss associated with psychotropic drugs in psychiatric inpatients-Data from an observational pharmacovigilance program in German-speaking countries. European Psychiatry : The Journal of the Association of European Psychiatrists, 54, 117–123.
DOI: 10.1016/j.eurpsy.2018.08.003

2017

Kasuistik / Fallserie
Ladwig J, Andreae D, Grohmann R, Toto S, Kropp S, Bleich S (2017). New Onset of Suicidal Impulses Following Abrupt Cessation of Valproate. Pharmacopsychiatry, 50(6), 270.
DOI: 10.1055/s-0043-109240

Kasuistik / Fallserie
Glocker C, Grohmann R, Schulz H (2017). Fatal Agranulocytosis Associated With Quetiapine in Monotherapy: A Case Report. Journal of Clinical Psychopharmacology, 37(5), 625–627.
DOI: 10.1097/JCP.0000000000000752

2016

Originalarbeit
Kleimann A, Schrader V, Stübner S, Greil W, Kahl KG, Bleich S, et al (2016). Psychopharmacological treatment of 1650 in-patients with acute mania-data from the AMSP study. Journal of Affective Disorders, 191, 164–171.
DOI: 10.1016/j.jad.2015.11.037

Originalarbeit
Friedrich ME, Akimova E, Huf W, Konstantinidis A, Papageorgiou K, Winkler D, et al (2016). Drug-Induced Liver Injury during Antidepressant Treatment: Results of AMSP, a Drug Surveillance Program. The International Journal of Neuropsychopharmacology, 19(4), pyv126.
DOI: 10.1093/ijnp/pyv126

Originalarbeit
Poppe C, Müller ST, Greil W, Walder A, Grohmann R, Stübner S (2016). Pharmacotherapy for obsessive compulsive disorder in clinical practice - Data of 842 inpatients from the International AMSP Project between 1994 and 2012. Journal of Affective Disorders, 200, 89–96.
DOI: 10.1016/j.jad.2016.04.035

2015

Kasuistik / Fallserie
Laoutidis ZG, Konstantinidis A, Grohmann R, Luckhaus C, Mobascher J, Cordes J (2015). Reversible Amisulpride-induced Elevation of Creatine Kinase (CK): A Case Series from the German AMSP Pharmacovigilance Project. Pharmacopsychiatry. 48(4-5):178-81.
DOI: 10.1055/s-0035-1549997

Originalarbeit
Holl AK, Grohmann R, Letmaier M, Painold A, Mörkl S, Toto S, Kasper S (2015). Pharmacotherapy of anxiety disorders in German-speaking countries: current status and changes between 1994 and 2011. European Archives of Psychiatry and Clinical Neuroscience, 265(3), 199–208.
DOI: 10.1007/s00406-014-0523-7

Originalarbeit
Bridler R, Häberle A, Müller ST, Cattapan K, Grohmann R, Toto S, et al (2015). Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders. European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, 25(6), 763–772.
DOI: 10.1016/j.euroneuro.2015.03.017

2014

Originalarbeit
Spindelegger CJ, Papageorgiou K, Grohmann R, Engel R, Greil W, Konstantinidis A, et al (2014). Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010. The International Journal of Neuropsychopharmacology, 18(4), pyu080.
DOI: 10.1093/ijnp/pyu080

Originalarbeit
Grohmann R, Engel RR, Möller HJ, Rüther E, van der Velden JW, Stübner S (2014). Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study. European Archives of Psychiatry and Clinical Neuroscience, 264(2):131-41.
DOI: 10.1007/s00406-013-0419-y

2013

Originalarbeit
Köster M, Grohmann R, Engel RR, Nitsche MA, Rüther E, Degner D (2013). Seizures during antidepressant treatment in psychiatric inpatients--results from the transnational pharmacovigilance project "Arzneimittelsicherheit in der Psychiatrie" (AMSP) 1993-2008. Psychopharmacology (Berl), 230(2):191-201.
DOI: 10.1007/s00213-013-3281-8

Originalarbeit
Zorina OI, Haueis P, Greil W, Grohmann R, Kullak-Ublick GA, Russmann S (2013). Comparative performance of two drug interaction screening programmes analysing a cross-sectional prescription dataset of 84,625 psychiatric inpatients. Drug Safety, 36(4), 247–258.
DOI: 10.1007/s40264-013-0027-9

Originalarbeit
Greil W, Häberle A, Schuhmann T, Grohmann R, Baumann P (2013). Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland. Swiss Medical Weekly, 143, w13772–w13772.
DOI: 10.4414/smw.2013.13772

Originalarbeit
Lange-Asschenfeldt C, Kojda G, Cordes J, Hellen F, Gillmann A, Grohmann R, Supprian T (2013). Epidemiology, symptoms, and treatment characteristics of hyponatremic psychiatric inpatients. Journal of Clinical Psychopharmacology, 33(6), 799–805.
DOI: 10.1097/JCP.0b013e3182a4736f

2012

Originalarbeit
Mundt AP, Aichberger MC, Fakhriddinov S, Fayzirahmanova M, Grohmann R, Heinz A, et al (2012). Prescription patterns of patients diagnosed with schizophrenia in mental hospitals in Tashkent/Uzbekistan and in four German cities. Pharmacoepidemiology and Drug Safety, 21(2), 145–151.
DOI: 10.1002/pds.2166

Originalarbeit
Letmaier M, Painold A, Holl AK, Vergin H, Engel R, Konstantinidis A, et al (2012). Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme. The International Journal of Neuropsychopharmacology, 15(6), 739–748.
DOI: 10.1017/S1461145711001192

Originalarbeit
Greil W, Häberle A, Haueis P, Grohmann R, Russmann S (2012). Pharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the International AMSP Project between 1994 and 2009. Journal of Affective Disorders, 136(3), 534–542.
DOI: 10.1016/j.jad.2011.10.033

Originalarbeit
Haueis P, Russmann S, Zorina OI, Grohmann R, Kullak-Ublick GA, Jaquenoud Sirot E, Russmann H (2012). Coprescription of levodopa with antipsychotics in a population of 84,596 psychiatric inpatients from 1994 to 2008. Pharmacopsychiatry,45(4):127-32.
DOI: 10.1055/s-0031-1291348

Kasuistik / Fallserie
Letmaier M, Painold A, Holl AK, Grohmann R, Vergin H (2012). Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone. International Journal of Psychiatry in Clinical Practice, 16(2), 153–156.
DOI: 10.3109/13651501.2011.644300

Originalarbeit
Konstantinidis A, Papageorgiou K, Grohmann R, Horvath A, Engel R, Kasper S (2012). Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program. International Journal of Neuropsychopharmacology, 15(4):449-57.
DOI: 10.1017/S1461145711000745

Originalarbeit
Haeberle A, Greil W, Russmann S, Grohmann R (2012). Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP. BMC Psychiatry, 12, 153.
DOI: 10.1186/1471-244X-12-153

2011

Originalarbeit
Haueis P, Greil W, Huber M, Grohmann R, Kullak-Ublick GA, Russmann S (2011). Evaluation of drug interactions in a large sample of psychiatric inpatients: a data interface for mass analysis with clinical decision support software. Clinical Pharmacology& Therapy. 90(4):588-96.
DOI: 10.1038/clpt.2011.150

Originalarbeit
Mundt AP, Fakhriddinov S, Fayzirahmanova M, Aichberger MC, Ivens S, Schouler-Ocak M, et al (2011). Use of psychiatric inpatient capacities and diagnostic practice in Tashkent/Uzbekistan as compared to Berlin/Germany. Social Psychiatry and Psychiatric Epidemiology, 46(12), 1295–1302.
DOI: 10.1007/s00127-010-0299-7

2010

Originalarbeit
Mundt A, Ströhle A, Heimann H, Heinz A, Grohmann R (2010). Pharmacoepidemiology of patients hospitalized for somatoform disorders in psychiatric hospitals and departments. Pharmacoepidemiology and Drug Safety, 19(7), 687–693.
DOI: 10.1002/pds.1976

Originalarbeit
Stübner S, Grohmann R, von Stralendorff I, Rüther E, Möller HJ, Müller-Oerlinghausen B, Horvath A, Greil W (2010). Suicidality as rare adverse event of antidepressant medication: report from the AMSP multicenter drug safety surveillance project. The Journal of Clinical Psychiatry, 71(10), 1293–1307.
DOI: 10.4088/JCP.09m05912blu

2009

Originalarbeit
Lange-Asschenfeldt C, Grohmann R, Lange-Asschenfeldt B, Engel RR, Rüther E, Cordes J (2009). Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program. The Journal of Clinical Psychiatry, 70(9), 1258–1265.
DOI: 10.4088/JCP.08m04563

2007

Originalarbeit
Wolfsperger M, Greil W, Rössler W, Grohmann R (2007). Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. Journal of Affective Disorders, 99(1–3), 9–17.
DOI: 10.1016/j.jad.2006.08.017

Methodik / Fachbeitrag
Conca A, Grohmann R, Di Pauli J, Hausmann A (2007). Is there a rationale in combining anticonvulsants for bipolar patients? Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 21(2), 159–171.
PubMed

2005

Kasuistik / Fallserie
Mobascher J, Zielasek J, Schuier FJ, Mobascher A, Grohmann R, Agelink MW, Cordes J (2005). Guillain-Barré syndrome after septicemia following clozapine-induced agranulocytosis. A case report. Pharmacopsychiatry, 38(6):329-30.
DOI: 10.1055/s-2005-916191

Originalarbeit
Heinze M, Andreae D, Grohmann R (2005). Pharmacotherapy of personality disorders in German speaking countries: state and changes in the last decade. Pharmacopsychiatry,38(5):201-5.
DOI: 10.1055/s-2005-873154

Originalarbeit
Zullino D, Mayland G, Schmidt LG, Fähndrich E, Greil W, Horvath A, Rüther E, Engel R, Hippius H, Baumann P (2005). Prescribing practices in German and Swiss psychiatric university and in non-university hospitals: national differences. International Journal of Clinical Pharmacology and Therapeutics. 43(7):339-49.
DOI: 10.5414/cpp43339

Kasuistik / Fallserie
Degner D, Kropp S, Porzig J, Grohmann R, Rüther E (2005). Pseudohallucinations associated with moclobemide: a case report. Pharmacopsychiatry. 38(4):179-81.
DOI: 10.1055/s-2005-871242

2004

Kasuistik / Fallserie
Cordes J, Streit M, Loeffler S, von Wilmsdorff M, Agelink M, Klimke A (2004). Reversible neutropenia during treatment with olanzapine: three case reports.The World Journal of Biological Psychiatry.5(4):230-4.
DOI: 10.1080/15622970410029938

Originalarbeit
Kropp S, Ziegenbein M, Grohmann R, Engel RR, Degner D (2004). Galactorrhea due to psychotropic drugs. Pharmacopsychiatry. 37 Suppl 1:S84-8.
DOI: 10.1055/s-2004-815515

Originalarbeit
Kropp S, Grohmann R, Hauser U, Rüther E, Degner D (2004). Hyperglycemia associated with antipsychotic treatment in a multicenter drug safety project. Pharmacopsychiatry. 37 Suppl 1:S79-83.
DOI: 10.1055/s-2004-815514

Originalarbeit
Stübner S, Grohmann R, Engel R, Bandelow B, Ludwig WD, Wagner G, Müller-Oerlinghausen B, Möller HJ, Hippius H, Rüther E (2004). Blood dyscrasias induced by psychotropic drugs. Pharmacopsychiatry. 37 Suppl 1:S70-8.
DOI: 10.1055/s-2004-815513

Originalarbeit
Schmid C, Grohmann R, Engel RR, Rüther E, Kropp S (2004). Cardiac adverse effects associated with psychotropic drugs. Pharmacopsychiatry. 37 Suppl 1:S65-9.
DOI: 10.1055/s-2004-815512

Originalarbeit
Stübner S, Rustenbeck E, Grohmann R, Wagner G, Engel R, Neundörfer G, Möller HJ, Hippius H, Rüther E (2004). Severe and uncommon involuntary movement disorders due to psychotropic drugs. Pharmacopsychiatry. 37 Suppl 1:S54-64.
DOI: 10.1055/s-2004-815511

Originalarbeit
Bender S, Grohmann R, Engel RR, Degner D, Dittmann-Balcar A, Rüther E (2004). Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics. Pharmacopsychiatry, 37 Suppl 1:S46-53.
DOI: 10.1055/s-2004-815510

Originalarbeit
Degner D, Grohmann R, Kropp S, Rüther E, Bender S, Engel RR, Schmidt LG (2004). Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry. 37 Suppl 1:S39-45.
DOI: 10.1055/s-2004-815509

Originalarbeit
Grohmann R, Engel RR, Geissler KH, Rüther E (2004). Psychotropic drug use in psychiatric inpatients: recent trends and changes over time-data from the AMSP study. Pharmacopsychiatry. 37 Suppl 1:S27-38.
DOI: 10.1055/s-2004-815508

Methodik / Fachbeitrag
Engel RR, Grohmann R, Rüther E, Hippius H (2004). Research methods in drug surveillance. Pharmacopsychiatry. 37 Suppl 1:S12-5.
DOI: 10.1055/s-2004-815506

Methodik / Fachbeitrag
Grohmann R, Engel RR, Rüther E, Hippius H (2004). The AMSP drug safety program: methods and global results. Pharmacopsychiatry. 37 Suppl 1:S4-11.
DOI: 10.1055/s-2004-815505

2000

Originalarbeit
Stübner S, Padberg F, Grohmann R, Hampel H, Hollweg M, Hippius H, Möller HJ, Rüther E (2000). Pisa syndrome (pleurothotonus): report of a multicenter drug safety surveillance project. J Clin Psychiatry. 61(8):569–574.
DOI: 10.4088/jcp.v61n0805

Übersichtsarbeit / Fachbeitrag
Degner D, Grohmann R, Bleich S, Rüther E (2000). Neue Antidepressiva. Mit welchen Nebenwirkungen und Interaktionen müssen Sie rechnen? [New antidepressant drugs. What side effects and interactions are to be expected?]. MMW Fortschritte der Medizin, 142(49-50):35-8, 40.

1999

Originalarbeit
Grohmann R, Rüther E, Engel RR, Hippius H (1999). Assessment of adverse drug reactions in psychiatric inpatients with the AMSP drug safety program: methods and first results for tricyclic antidepressants and SSRI. Pharmacopsychiatry. 32(1):21-8.
DOI: 10.1055/s-2007-979184